Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis.
Holroyd CR, Parker L, Bennett S, Zarroug J, Underhill C, Davidson B, Armstrong R, Harvey NC, Dennison E, Cooper C, Edwards CJ.
Holroyd CR, et al. Among authors: davidson b.
Clin Exp Rheumatol. 2018 Jan-Feb;36(1):171-172. Epub 2018 Jan 15.
Clin Exp Rheumatol. 2018.
PMID: 29352847
No abstract available.